These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of zinc-fingers and homeoboxes 2 in hepatocellular carcinogenesis: a tissue microarray and clinicopathological analysis. Hu S, Zhang M, Lv Z, Bi J, Dong Y, Wen J. Neoplasma; 2007; 54(3):207-11. PubMed ID: 17447851 [Abstract] [Full Text] [Related]
3. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Zhong S, Yeo W, Tang MW, Wong N, Lai PB, Johnson PJ. Clin Cancer Res; 2003 Aug 15; 9(9):3376-82. PubMed ID: 12960125 [Abstract] [Full Text] [Related]
4. [The methylation of ZHX2 gene promoter enhances AFP gene expression in hepatocellular carcinoma]. Lv Z, DU Y, Wen J. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul 15; 29(7):706-9. PubMed ID: 23837980 [Abstract] [Full Text] [Related]
5. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW. Cancer; 2006 Aug 01; 107(3):579-90. PubMed ID: 16795071 [Abstract] [Full Text] [Related]
6. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y. Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857 [Abstract] [Full Text] [Related]
8. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma. Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS. Genes Chromosomes Cancer; 2009 Dec 15; 48(12):1057-68. PubMed ID: 19760608 [Abstract] [Full Text] [Related]
9. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G. Gastroenterology; 2008 Dec 15; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366 [Abstract] [Full Text] [Related]
10. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI. Gastroenterology; 2007 Apr 15; 132(4):1476-94. PubMed ID: 17408664 [Abstract] [Full Text] [Related]
11. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ. Clin Cancer Res; 2002 Apr 15; 8(4):1087-92. PubMed ID: 11948118 [Abstract] [Full Text] [Related]
12. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K. Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447 [Abstract] [Full Text] [Related]
13. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma. Kim CJ, Song JH, Cho YG, Cao Z, Lee YS, Nam SW, Lee JY, Park WS. Histopathology; 2008 Apr 02; 52(5):552-9. PubMed ID: 18312352 [Abstract] [Full Text] [Related]
14. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation. Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS. Ann Surg Oncol; 2008 Dec 02; 15(12):3494-502. PubMed ID: 18830757 [Abstract] [Full Text] [Related]
15. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A. Liver Int; 2005 Apr 02; 25(2):380-8. PubMed ID: 15780064 [Abstract] [Full Text] [Related]
16. Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma. Luan F, Liu P, Ma H, Yue X, Liu J, Gao L, Liang X, Ma C. Int J Biochem Cell Biol; 2014 Oct 02; 55():129-35. PubMed ID: 25195714 [Abstract] [Full Text] [Related]
17. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Oh BK, Kim H, Park HJ, Shim YH, Choi J, Park C, Park YN. Int J Mol Med; 2007 Jul 02; 20(1):65-73. PubMed ID: 17549390 [Abstract] [Full Text] [Related]
18. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Fukai K, Yokosuka O, Chiba T, Hirasawa Y, Tada M, Imazeki F, Kataoka H, Saisho H. Cancer Res; 2003 Dec 15; 63(24):8674-9. PubMed ID: 14695180 [Abstract] [Full Text] [Related]
19. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI. Gastroenterology; 2010 May 15; 138(5):1898-908. PubMed ID: 20038433 [Abstract] [Full Text] [Related]
20. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element. Liedtke C, Zschemisch NH, Cohrs A, Roskams T, Borlak J, Manns MP, Trautwein C. Gastroenterology; 2005 Nov 15; 129(5):1602-15. PubMed ID: 16285959 [Abstract] [Full Text] [Related] Page: [Next] [New Search]